The evidence that modulation of the BDNF-depression association occurs primarily at low IFN-γ levels suggests that under elevated inflammatory conditions, as found, e.g., in severe obesity (54), the ability of BDNF to impact on depressive symptoms is potentially negligible. The gene discussed is BDNF; the disease is obesity due to melanocortin 4 receptor deficiency.